Corient Private Wealth’s Celularity Inc CELUW Stock Holding History

Corient Private Wealth’s Portfolio CELUW Stock Details CELUW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$225	Sell	50,000 -5,000	-9%	-$34	﹤0.01%	3042
2026 Q1	$545	Sell	55,000 -1,200	-2%	-$14	﹤0.01%	2822
2025 Q4	$916	Buy	56,200 +1,200	+2%	+$30	﹤0.01%	2638
2025 Q3	$1.93K	Hold	55,000	–	–	﹤0.01%	2547
2025 Q2	$2.44K	Hold	55,000	–	–	﹤0.01%	2430
2025 Q1	$2.2K	Hold	55,000	–	–	﹤0.01%	2273
2024 Q4	$990	Hold	55,000	–	–	﹤0.01%	2342
2024 Q3	$556	Buy	+55,000	New	+$946	﹤0.01%	2455
2023 Q4	–	Sell	-14,800	Closed	-$225	–	2261
2023 Q3	$225	Buy	+14,800	New	+$509	﹤0.01%	2137
2023 Q2	–	Sell	-14,800	Closed	-$888	–	2088
2023 Q1	$888	Buy	+14,800	New	+$1.23K	﹤0.01%	2002

Other funds holding CELUW

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

LOAME

Lombard Odier Asset Management (Europe) London, United Kingdom $2.37B AUM 28.81% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

WCM

Weaver Capital Management Suwanee, Georgia $454M AUM 20.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Corient Private Wealth's CELUW Position: Q2 2026 in Review

Corient Private Wealth reduced its Celularity Inc (CELUW) stake by 9.1% in Q2 2026, selling an estimated $34 and leaving 50,000 shares worth $225. The position accounts for ﹤0.01% of the portfolio, ranked #3042.

Corient Private Wealth first reported a position in CELUW in Q1 2023 and has held it in 10 quarters since. The position peaked at $2.44K in Q2 2025. 16 funds tracked by Wall St. Rank hold CELUW as of Q2 2026.

Corient Private Wealth held 50,000 shares of Celularity Inc worth $225 as of Q2 2026.
Corient Private Wealth sold 5,000 Celularity Inc shares in Q2 2026, an estimated $34.
Celularity Inc made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #3042 holding.
Corient Private Wealth first reported a position in Celularity Inc in Q1 2023 and has held it in 10 quarters since.
Corient Private Wealth's Celularity Inc position peaked at $2.44K in Q2 2025.
16 funds tracked by Wall St. Rank held Celularity Inc as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.